Ajanta Pharma Ltd is quoting at Rs 3526.8, up 0.37% on the day as on 12:44 IST on the NSE. The stock is up 33.8% in last one year as compared to a 0.63% spurt in NIFTY and a 20.67% spurt in the Nifty ...

Ajanta Pharma Ltd on Thursday reported a 31 per cent rise in profit after tax to Rs 334 crore for the first quarter ended ...

Ajanta Pharma reported double-digit growth in revenue and profit for the June quarter, supported by higher sales in its India ...

Ajanta Pharma Ltd (BOM:532331) reported a 14% growth in revenue from operations for the quarter, indicating strong business performance. The company declared a first interim dividend of INR28 per ...

Total Revenue (Q4): INR 1,170 crore, growth of 11% from INR 1,054 crore. Total Revenue (FY 2025): INR 4,648 crore, growth of 10% from INR 4,209 crore. Branded Generic Business Revenue (Q4): INR 805 ...

Ajanta Pharma reported a strong June quarter, with higher sales across key markets and a sharp jump in US generics driving ...

Ajanta Pharma Q1 Result. The company, on Thursday, reported a net profit after tax (PAT) of Rs 334 crore in Q1FY27. The ...

New Delhi, Jul 30 (PTI) Ajanta Pharma Ltd on Thursday reported a 31 per cent rise in profit after tax to Rs 334 crore for the ...

Ajanta Pharma reported a 31% rise in Q1 profit, driven by strong growth in its US generics and India businesses. The board ...

Ajanta Pharma Ltd on Thursday reported a 66 per cent year-on-year (YoY) rise in profit after tax (PAT) at Rs 203 crore for the March quarter compared with Rs 122 crore in the same quarter last year.

Ajanta Pharma Ltd reported a healthy improvement in earnings for the third quarter of FY26, supported by strong revenue growth and stable operating margins. Net profit for the December quarter rose 17 ...

Limited review financial results on quarterly basis, and audited financial results annually, both consolidated and standalone are published by the company on regular basis. FY 2026 reflects another ...